Recombinant 11-de-O-methyltomaymycin Production Yield

Solution Overview

Problem

Current methods for producing tomaymycin result in unsatisfactory yields, highlighting a need for an effective method to produce high amounts of this antibiotic.

Innovation Solution

A method involving the use of a DNA nucleic acid sequence (SEQ ID NO: 3) or its variants, introduced into a Streptomyces strain, specifically Streptomyces albus J1074, to express the tomaymycin biosynthetic gene cluster, enabling the production of 11-de-O-methyltomaymycin.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional media and methods are used for tomaymycin production, then the production process is simple, but the yield is unsatisfactory and low

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent optimizes cultural conditions including pH (adjusted to 7.0-7.5), temperature (28-30°C), aeration rate (1.5-2.0 vvm), and agitation speed (600-800 rpm) to maximize tomaymycin yield. The production medium composition is also optimized with specific concentrations of soybean flour (20 g/L), corn steep powder (10 g/L), glycerol (20 g/L), and other nutrients to achieve high productivity of 338 ± 18.8 mg/L

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs a two-stage fermentation process: a growth phase (48-72 hours) to build biomass, followed by a production phase where tomaymycin is synthesized. This preliminary separation of growth and production phases allows optimization of conditions for each stage, resulting in significantly enhanced yield compared to continuous conventional methods

Inventive Principle:
Principle #10Preliminary action

2Productivity

If Streptomyces achromogenes var. tomaymyceticus is used for production, then the natural production capability is maintained, but the yield remains low at 20 mg/L

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent uses Streptomyces albus J1074 as a heterologous host organism to express the tomaymycin biosynthetic gene cluster from S. achromogenes. This intermediary approach allows the production system to benefit from the optimized cultural conditions and higher biomass capacity of S. albus while producing tomaymycin, achieving yields of 338 ± 18.8 mg/L compared to only 20 mg/L with the native strain

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the production yield of 11-de-O-methyltomaymycin, achieving a significant increase in productivity compared to standard methods, with Streptomyces albus J1074 producing 338 ± 18.8 mg/l, whereas the standard strain produces 20 mg/l under similar conditions.

Implementation Method 1

A method involving the use of a DNA nucleic acid sequence (SEQ ID NO: 3) or its variants, introduced into a Streptomyces strain, specifically Streptomyces albus J1074, to express the tomaymycin biosynthetic gene cluster, enabling the production of 11-de-O-methyltomaymycin

Methodology Applied
Scientific EffectRecombinant DNA expression:

Data Source

PatentEP2849753B1Method for producing recombinant 11-de-o-methyltomaymycin
Publication Date: 2022.08.10
  • EP2849753B1 patent drawingFigure 1~2
  • EP2849753B1 patent drawingFigure 3
  • EP2849753B1 patent drawingFigure 4A

AI summary

The present invention provides a tomaymycin biosynthetic gene cluster of Streptomyces species FH6421,and its use for producing 11-de-O-methyltomaymycin.